Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Fisher

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Human Brain Mapping|September 16, 2014
BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levelsPatrick M Fisher, Klaus K Holst, Dea Adamsen, et al.
Translational Psychiatry|May 21, 2025
Computational modelling and neural correlates of reinforcement learning following three-week escitalopram: a double-blind, placebo-controlled semi-randomised studyChristelle Langley, Graham K Murray, Sophia Armand, et al.
The American Journal of Psychiatry|December 3, 2008
Altered striatal activation predicting real-world positive affect in adolescent major depressive disorderErika E Forbes, Ahmad R Hariri, Samantha L Martin, et al.
Psychological Medicine|April 18, 2024
Longitudinal changes in resting-state functional connectivity as markers of vulnerability or resilience in first-degree relatives of patients with bipolar disorderJulian Macoveanu, Lydia Fortea, Hanne Lie Kjærstad, et al.
Neuroscience Applied|July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsyMaja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Bipolar Disorders|May 2, 2024
Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI studyHanne Lie Kjærstad, Luisa de Siqueira Rotenberg, Julian Macoveanu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disordersKamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Frontiers in Neurology|December 14, 2018
Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG (CONNECT-ME): Protocol for a Longitudinal Prospective Study and a Tertiary Clinical Care ServiceAnine P Skibsted, Moshgan Amiri, Patrick M Fisher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 2, 2021
Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in ratsAgata Casado-Sainz, Frederik Gudmundsen, Simone L Baerentzen, et al.
Frontiers in Psychiatry|August 15, 2020
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial ProtocolKristin Köhler-Forsberg, Anders Jorgensen, Vibeke H Dam, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Human Brain Mapping|September 16, 2014
BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levelsPatrick M Fisher, Klaus K Holst, Dea Adamsen, et al.
Translational Psychiatry|May 21, 2025
Computational modelling and neural correlates of reinforcement learning following three-week escitalopram: a double-blind, placebo-controlled semi-randomised studyChristelle Langley, Graham K Murray, Sophia Armand, et al.
The American Journal of Psychiatry|December 3, 2008
Altered striatal activation predicting real-world positive affect in adolescent major depressive disorderErika E Forbes, Ahmad R Hariri, Samantha L Martin, et al.
Psychological Medicine|April 18, 2024
Longitudinal changes in resting-state functional connectivity as markers of vulnerability or resilience in first-degree relatives of patients with bipolar disorderJulian Macoveanu, Lydia Fortea, Hanne Lie Kjærstad, et al.
Neuroscience Applied|July 14, 2025
The BrainDrugs-epilepsy study: A prospective open-label cohort precision medicine study in epilepsyMaja R Marstrand-Joergensen, Vibeke H Dam, Kirsten Vinter, et al.
Bipolar Disorders|May 2, 2024
Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: A prospective fMRI studyHanne Lie Kjærstad, Luisa de Siqueira Rotenberg, Julian Macoveanu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2025
Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disordersKamilla W Miskowiak, Brice Ozenne, Hanne L Kjærstad, et al.
Frontiers in Neurology|December 14, 2018
Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG (CONNECT-ME): Protocol for a Longitudinal Prospective Study and a Tertiary Clinical Care ServiceAnine P Skibsted, Moshgan Amiri, Patrick M Fisher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 2, 2021
Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in ratsAgata Casado-Sainz, Frederik Gudmundsen, Simone L Baerentzen, et al.
Frontiers in Psychiatry|August 15, 2020
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial ProtocolKristin Köhler-Forsberg, Anders Jorgensen, Vibeke H Dam, et al.
Pageof 9